Day 2 Afternoon: Peripheral Techniques & Technologies - Wednesday, 24th April
Venue: Theatre 3
Time: 13:30 - 15:20
Inaugural Roger M Greenhalgh Late Breaking Trials Session
Time: 13:30 - 15:20
ATK Trials
Time: 13:30 - 14:35
| Anchor: | Marianne Brodmann, Graz, Austria |
| Moderators: | Gunnar Tepe, Rosenheim, Germany |
| Thomas Zeller, Bad Krozingen, Germany |
13:30 - 13:35
Achieving long term patency with a self-expanding covered endoprosthesis in the SFA: 5-year outcomes from the Japanese post-market study
| Speaker: | Tatsuya Nakama, Chiba, Japan |
13:35 - 13:40
New interwoven double mesh nitinol stent for femoropopliteal disease: Preliminary results from a multicenter regional registry
| Speaker: | Gianmarco de Donato, Siena, Italy |
13:40 - 13:45
ZILVERPASS trial 5-year results and economic analysis
| Speaker: | Michel Bosiers, Bern, Switzerland |
13:45 - 13:55
Audience participation & discussion
13:55 - 14:00
Podium First: 6-month data from the SHOCC study
| Speaker: | Athanasios Saratzis, Leicester, United Kingdom |
14:00 - 14:05
Podium First: First look at the PREVISION FIH Trial evaluating the novel sirolimus DCB catheter
| Speaker: | Andrew Holden, Auckland, New Zealand |
14:05 - 14:10
Audience participation & discussion
14:10 - 14:15
Podium First: Safety and efficacy metrics of a trans-venous arterial bypass system: Pooled analysis and comprehensive evaluation of current objective performance goals
| Speaker: | Peter Schneider, San Francisco, United States |
14:15 - 14:20
The impact of non-pulsatile deformations in native and treated femoropopliteal arteries
| Speaker: | Christopher Cheng, Stanford, United States |
14:20 - 14:25
STRIDE Study sub-analysis: Reported outcomes by sex and on patients receiving aspiration mechanical thrombectomy alone
| Speaker: | Heiko Wendorff, Ebersberg, Germany |
14:25 - 14:35
Audience participation & discussion
BTK Trials
Time: 14:35 - 15:20
| Anchor: | Marianne Brodmann, Graz, Austria |
| Moderators: | Gunnar Tepe, Rosenheim, Germany |
| Thomas Zeller, Bad Krozingen, Germany |
14:35 - 14:40
The TOBA II Study below-the-knee trial: 36-month results
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
14:40 - 14:45
Podium First: First results of the SAMBA Trial: A randomised trial comparing a paclitaxel DCB to POBA in BTK Arteries
| Speaker: | Gunnar Tepe, Rosenheim, Germany |
14:45 - 14:50
The use of combination directional atherectomy and DCB in tibial artery disease
| Speaker: | Vikram Puttaswamy, St Leonards, Australia |
14:50 - 15:00
Audience participation & discussion
15:00 - 15:05
Diagnosis of silent coronary ischaemia with selective coronary revascularisation might improve 2-year survival of patients with critical limb-threatening ischaemia
| Speaker: | Dainis Krievins, Riga, Latvia |
15:05 - 15:10
Podium First: Interim analysis of the DEEPER REVEAL trial
| Speaker: | Mahmood Razavi, Stockton, United States |
15:10 - 15:15
Podium First: Final results of the DEEPER LIMUS trial
| Speaker: | Leyla Schweiger, Graz, Austria |
15:15 - 15:20
Audience participation & discussion